These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20101762)

  • 1. Fluorescence lifetime imaging of activatable target specific molecular probes.
    Alford R; Ogawa M; Hassan M; Gandjbakhche AH; Choyke PL; Kobayashi H
    Contrast Media Mol Imaging; 2010; 5(1):1-8. PubMed ID: 20101762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.
    Ogawa M; Kosaka N; Longmire MR; Urano Y; Choyke PL; Kobayashi H
    Mol Pharm; 2009; 6(2):386-95. PubMed ID: 19718793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
    Ogawa M; Regino CA; Seidel J; Green MV; Xi W; Williams M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Nov; 20(11):2177-84. PubMed ID: 19919110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.
    Ogawa M; Regino CA; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2009 Jan; 8(1):232-9. PubMed ID: 19139133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
    Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
    Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Jan; 20(1):147-54. PubMed ID: 19072537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Cancer Res; 2009 Feb; 69(4):1268-72. PubMed ID: 19176373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu.
    Koyama Y; Hama Y; Urano Y; Nguyen DM; Choyke PL; Kobayashi H
    Clin Cancer Res; 2007 May; 13(10):2936-45. PubMed ID: 17504994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation.
    Ogawa M; Kosaka N; Regino CA; Mitsunaga M; Choyke PL; Kobayashi H
    Mol Biosyst; 2010 May; 6(5):888-93. PubMed ID: 20567775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence lifetime imaging system for in vivo studies.
    Hassan M; Riley J; Chernomordik V; Smith P; Pursley R; Lee SB; Capala J; Gandjbakhche AH
    Mol Imaging; 2007; 6(4):229-36. PubMed ID: 17711778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.
    Nakajima T; Mitsunaga M; Bander NH; Heston WD; Choyke PL; Kobayashi H
    Bioconjug Chem; 2011 Aug; 22(8):1700-5. PubMed ID: 21740058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
    Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
    Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
    Koyama Y; Barrett T; Hama Y; Ravizzini G; Choyke PL; Kobayashi H
    Neoplasia; 2007 Dec; 9(12):1021-9. PubMed ID: 18084609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes.
    Urano Y; Asanuma D; Hama Y; Koyama Y; Barrett T; Kamiya M; Nagano T; Watanabe T; Hasegawa A; Choyke PL; Kobayashi H
    Nat Med; 2009 Jan; 15(1):104-9. PubMed ID: 19029979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells.
    Burks SR; Macedo LF; Barth ED; Tkaczuk KH; Martin SS; Rosen GM; Halpern HJ; Brodie AM; Kao JP
    Breast Cancer Res Treat; 2010 Nov; 124(1):121-31. PubMed ID: 20066490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In-vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes].
    Chen LD; Liu J; Yu XF; Pang DW; Wang QQ; Yuan HY; Tang ZY; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):394-9. PubMed ID: 17822625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases.
    Hama Y; Urano Y; Koyama Y; Gunn AJ; Choyke PL; Kobayashi H
    Clin Cancer Res; 2007 Nov; 13(21):6335-43. PubMed ID: 17975145
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.